
Quarterly report 2025-Q2
added 07-31-2025
iRhythm Technologies Financial Ratios 2011-2025 | IRTC
Annual Financial Ratios iRhythm Technologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-30.8 | -28.8 | -27.7 | -34.1 | -150.2 | -40.2 | -42.4 | -46.4 | -8.0 | - | - | - | - | - |
P/S |
5.9 | 7.2 | 7.8 | 10.7 | 24.8 | 10.2 | 13.9 | 13.9 | 2.6 | - | - | - | - | - |
EPS |
-3.6 | -4.0 | -3.9 | -3.5 | -1.6 | -2.2 | -2.1 | -1.3 | -4.0 | -16.6 | -12.1 | - | - | - |
EV (Enterprise Value) |
3.91 B | 3.74 B | 3.34 B | 3.51 B | 6.67 B | 2.35 B | 2.09 B | 1.41 B | 160 M | 114 M | 90.4 M | - | - | - |
EBITDA per Share |
-3.04 | -3.57 | -3.36 | -3.07 | -1.32 | -2.03 | -1.73 | -1.13 | -2.84 | - | - | - | - | - |
EV/EBITDA |
-38.7 | -127.0 | -43.1 | -49.9 | -54.2 | -9.8 | - | - | - | - | - | |||
PEG |
-1.56 | -1.1 | -0.78 | -1.59 | 4.01 | -5.8 | -0.77 | 0.69 | -0.05 | - | - | - | - | - |
P/B |
38.4 | 16.9 | 13.4 | 12.3 | 19.3 | 16.2 | 37.6 | 17.2 | 1.8 | - | - | - | - | - |
P/CF |
1029.2 | -70.9 | -139.7 | -91.4 | -478.5 | -51.9 | -59.8 | -73.9 | -8.6 | - | - | - | - | - |
ROE % |
-124.62 | -58.74 | -48.44 | -36.26 | -12.83 | -40.30 | -88.71 | -36.98 | -22.58 | - | - | - | - | - |
ROA % |
-12.16 | -28.49 | -25.91 | -21.89 | -8.56 | -17.82 | -40.33 | -22.10 | -15.13 | - | - | - | - | - |
ROCE % |
-127.06 | -59.57 | -47.45 | -35.76 | -12.78 | -21.54 | -48.75 | -24.30 | -12.47 | - | - | - | - | - |
Current Ratio |
1.1 | 1.9 | 2.2 | 2.5 | 3.0 | 3.3 | 3.5 | 5.7 | 9.0 | - | - | - | - | - |
DSO |
43.6 | 41.3 | 42.8 | 43.2 | 37.0 | 40.6 | 54.5 | 48.0 | 53.6 | - | - | - | - | - |
DIO |
27.7 | 33.0 | 35.9 | 26.0 | 24.3 | 28.1 | 19.5 | 22.2 | 24.3 | - | - | - | - | - |
DPO |
12.6 | 14.8 | 25.4 | 24.8 | 32.7 | 57.3 | 21.6 | 31.5 | 36.8 | - | - | - | - | - |
Operating Cycle |
71.3 | 74.3 | 78.7 | 69.2 | 61.3 | 68.7 | 74.0 | 70.2 | 77.9 | - | - | - | - | - |
Cash Conversion Cycle |
58.7 | 59.5 | 53.2 | 44.4 | 28.6 | 11.4 | 52.4 | 38.6 | 41.1 | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios iRhythm Technologies
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.44 | -0.97 | - | -1.48 | -0.65 | -1.47 | - | -0.89 | -0.61 | -1.29 | - | -0.71 | -0.8 | -1.71 | - | -0.81 | -0.59 | -0.95 | -0.33 | -0.17 | -0.75 | -0.34 | -0.65 | -0.72 | -0.43 | -0.34 | -0.67 | -2.11 | -0.56 | -0.47 | -0.48 | -0.29 | -0.29 | -0.24 | -0.37 | -2.8 | -3.09 | -4.34 | -5.46 | -4.07 | -3.66 | -3.31 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.43 | -0.87 | - | -1.45 | -0.57 | -1.06 | - | -0.77 | -0.49 | -1.19 | - | -0.59 | -0.67 | -1.54 | - | -0.71 | -0.5 | -0.87 | - | -0.11 | -0.68 | -0.28 | - | -0.69 | -0.4 | -0.31 | - | -1.87 | -0.51 | -0.43 | - | -0.24 | -0.25 | -0.2 | - | -1.7 | -2.44 | -3.29 | - | -3.69 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-177.84 | -184.40 | -135.20 | -147.54 | -95.52 | -83.51 | -38.22 | -47.19 | -43.82 | -45.33 | -39.41 | -47.43 | -46.48 | -42.38 | -22.66 | -25.49 | -18.83 | -19.15 | -12.83 | -22.78 | -34.92 | -36.86 | -40.30 | -58.73 | -141.85 | -158.37 | -172.63 | -155.48 | -67.05 | -50.71 | -37.02 | -29.70 | -25.90 | -22.60 | -22.55 | -8.23 | 1.82 | 6.61 | 13.23 | 5.65 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-14.94 | -15.66 | -12.28 | -18.45 | -19.54 | -21.65 | -19.74 | -24.61 | -23.32 | -30.82 | -28.48 | -33.42 | -21.69 | -25.27 | -14.32 | -16.21 | -12.18 | -12.60 | -8.56 | -12.33 | -17.39 | -16.90 | -17.82 | -26.01 | -62.91 | -70.52 | -77.08 | -71.59 | -33.63 | -27.35 | -22.08 | -18.26 | -16.31 | -14.68 | -15.13 | -30.93 | -43.15 | -39.94 | -35.51 | -15.17 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-195.80 | -200.92 | -135.50 | -148.06 | -90.53 | -75.79 | -38.80 | -47.61 | -43.87 | -45.02 | -38.23 | -46.10 | -45.15 | -41.11 | -22.29 | -23.68 | -17.20 | -17.56 | -9.98 | -23.46 | -35.56 | -37.46 | -27.35 | -114.98 | -189.13 | -204.82 | -130.60 | -138.12 | -58.00 | -41.96 | -20.93 | -23.81 | -19.17 | -15.72 | -12.14 | -6.72 | 1.57 | 5.56 | 5.41 | 5.41 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.9 | 2.0 | 2.1 | 2.1 | 2.1 | 2.2 | - | 2.3 | 2.5 | 2.6 | 2.7 | 2.8 | 3.0 | 3.0 | 3.0 | 3.0 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 2.5 | 2.5 | 2.5 | 2.5 | 3.0 | 3.0 | 3.0 | 3.0 | 0.9 | 0.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
39.8 | 46.2 | - | 50.4 | 54.0 | 52.3 | - | 37.0 | 37.0 | 40.7 | - | 26.6 | 24.7 | 50.2 | - | 62.1 | 69.3 | 55.2 | 34.7 | 38.0 | 53.7 | 38.6 | 36.9 | 39.8 | 41.5 | 41.2 | 43.2 | 12.9 | 56.8 | 52.4 | 42.2 | 47.2 | 49.5 | 47.6 | 45.9 | 51.1 | 54.5 | 53.2 | 46.9 | 27.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
27.8 | 26.2 | - | 30.2 | 31.0 | 29.6 | - | 30.5 | 37.1 | 40.2 | - | 20.0 | 17.9 | 33.9 | - | 29.9 | 28.3 | 23.7 | - | 26.6 | 31.3 | 26.6 | - | 26.7 | 28.3 | 23.6 | - | 4.8 | 19.8 | 20.0 | - | 22.2 | 22.8 | 22.1 | - | 24.0 | 24.6 | 24.8 | - | 13.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
20.9 | 17.7 | - | 20.8 | 22.4 | 14.4 | - | 15.6 | 20.4 | 22.1 | - | 10.2 | 7.8 | 23.7 | - | 21.6 | 24.7 | 18.5 | - | 21.9 | 25.7 | 35.8 | - | 54.6 | 57.8 | 40.8 | - | 5.4 | 22.0 | 25.0 | - | 31.6 | 32.4 | 32.4 | - | 36.3 | 37.2 | 34.9 | - | 17.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
67.5 | 72.3 | - | 80.6 | 85.0 | 81.9 | - | 67.5 | 74.2 | 81.0 | - | 46.6 | 42.6 | 84.1 | - | 92.0 | 97.6 | 78.9 | 34.7 | 64.5 | 85.0 | 65.2 | 36.9 | 66.5 | 69.8 | 64.8 | 43.2 | 17.8 | 76.7 | 72.4 | 42.2 | 69.4 | 72.3 | 69.7 | 45.9 | 75.2 | 79.2 | 78.0 | 46.9 | 41.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
46.6 | 54.7 | - | 59.7 | 62.6 | 67.6 | - | 52.0 | 53.8 | 58.9 | - | 36.4 | 34.8 | 60.4 | - | 70.5 | 72.8 | 60.4 | 34.7 | 42.7 | 59.3 | 29.4 | 36.9 | 12.0 | 12.0 | 24.1 | 43.2 | 12.4 | 54.7 | 47.4 | 42.2 | 37.8 | 39.9 | 37.3 | 45.9 | 38.8 | 41.9 | 43.1 | 46.9 | 23.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company iRhythm Technologies, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Medical instruments industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Baxter International
BAX
|
$ 18.99 | 0.48 % | $ 9.68 B | ||
|
Becton, Dickinson and Company
BDX
|
$ 200.87 | 0.22 % | $ 57.8 B | ||
|
BioLife Solutions
BLFS
|
$ 24.43 | -1.81 % | $ 1.13 B | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | ||
|
Ekso Bionics Holdings
EKSO
|
$ 4.79 | 2.35 % | $ 96.6 M | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.59 | -0.13 % | $ 2.36 B | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | ||
|
Alcon
ALC
|
$ 78.74 | -0.03 % | $ 40.4 B | ||
|
AtriCure
ATRC
|
$ 42.08 | 1.62 % | $ 1.98 B | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | ||
|
electroCore
ECOR
|
$ 4.81 | -0.21 % | $ 26.5 K | ||
|
Harvard Bioscience
HBIO
|
$ 0.76 | 1.78 % | $ 32.2 M | ||
|
AngioDynamics
ANGO
|
$ 13.12 | -2.42 % | $ 536 M | ||
|
The Cooper Companies
COO
|
$ 81.82 | -0.36 % | $ 16.3 B | ||
|
ICU Medical
ICUI
|
$ 147.72 | 0.34 % | $ 3.6 B | ||
|
Glaukos Corporation
GKOS
|
$ 109.57 | 0.31 % | $ 5.31 B | ||
|
Haemonetics Corporation
HAE
|
$ 83.2 | -1.49 % | $ 4.19 B | ||
|
InfuSystem Holdings
INFU
|
$ 9.24 | 0.33 % | $ 191 M | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | ||
|
Repro Med Systems
KRMD
|
$ 5.75 | -1.88 % | $ 262 M | ||
|
LeMaitre Vascular
LMAT
|
$ 83.51 | 0.18 % | $ 1.87 B | ||
|
Intuitive Surgical
ISRG
|
$ 541.3 | -1.11 % | $ 192 B | ||
|
Masimo Corporation
MASI
|
$ 138.1 | -2.25 % | $ 7.36 B | ||
|
Merit Medical Systems
MMSI
|
$ 86.52 | -0.01 % | $ 5.04 B | ||
|
Microbot Medical
MBOT
|
$ 2.43 | 2.21 % | $ 24.8 M | ||
|
Milestone Scientific
MLSS
|
$ 0.39 | 9.69 % | $ 31.1 M | ||
|
Nephros
NEPH
|
$ 5.08 | 2.24 % | $ 52.8 M | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | ||
|
ResMed
RMD
|
$ 250.7 | -0.67 % | $ 36.6 B | ||
|
Envista Holdings Corporation
NVST
|
$ 21.79 | -1.58 % | $ 3.75 B | ||
|
OraSure Technologies
OSUR
|
$ 2.52 | -2.14 % | $ 188 M | ||
|
Pro-Dex
PDEX
|
$ 43.83 | 0.6 % | $ 144 M | ||
|
Pulse Biosciences
PLSE
|
$ 14.26 | 3.71 % | $ 685 M | ||
|
Predictive Oncology
POAI
|
$ 5.95 | 0.51 % | $ 32.4 M | ||
|
Repligen Corporation
RGEN
|
$ 156.65 | -3.1 % | $ 8.73 M | ||
|
Retractable Technologies
RVP
|
$ 0.83 | -0.31 % | $ 24.8 M | ||
|
STAAR Surgical Company
STAA
|
$ 24.16 | -2.11 % | $ 1.19 B | ||
|
STERIS plc
STE
|
$ 251.01 | -0.59 % | $ 24.7 B | ||
|
Stereotaxis
STXS
|
$ 2.38 | -1.45 % | $ 192 M | ||
|
Teleflex Incorporated
TFX
|
$ 125.81 | -1.13 % | $ 5.89 B | ||
|
Utah Medical Products
UTMD
|
$ 57.99 | 0.5 % | $ 210 M | ||
|
West Pharmaceutical Services
WST
|
$ 266.92 | -2.06 % | $ 19.5 B |